DVBCWPM1.m

DVBCWPM1 ;ALB/ESW PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 10 Oct 2000

 ;;2.7;AMIE;**34**;Apr 10, 1995

 ;

TXT ;

 ;;A. Review of Medical Records:

 ;;

 ;;B. Medical History (Subjective Complaints):

 ;;    Comment on:

 ;;

 ;;    1. Activity of pulmonary tuberculosis or other mycobacterial disease. 

 ;;    2. Date of inactivity if it is not active.

 ;;    3. Identity of organism (if possible).

 ;;

 ;;C. Physical examination (Objective Findings):

 ;;    Address each of the following and fully describe current findings:

 ;;

 ;;    1. Extent of structural damage to lungs.

 ;;    2. If patient was hospitalized for 6 months or more, what is the

 ;;       condition at the end of hospitalization?

 ;;    3. If patient was hospitalized for 12 months or more, what is the

 ;;        condition at the end of hospitalization?

 ;;

 ;;D. Diagnostic and Clinical Tests:

 ;;Provide:

 ;;

 ;;1. Pulmonary Function Tests, if indicated. If performed, include the results

 ;;   in the examination report, The FEV-1,FVC, and FEV-1/FVC should be included.

 ;;   Both pre- and post-bronchodilatation pulmonary function test results should

 ;;   be reported. If post-bronchodilatation test is not conducted in a particular

 ;;   case, please provide an explanation of why not. A DLCO may or may not be

 ;;   done routinely as part of pulmonary function testing at a particular

 ;;   facility. If there is a disparity between the results of different tests,

 ;;   please indicate which tests are more likely to accurately reflect

 ;;   the severity of the condition.

 ;;

 ;;      DLCO note: If DLCO was not done as a routine part of pulmonary function

 ;;      testing, the examiner should use his or her judgment, based on

 ;;      the specific condition (.e.g., whether it is obstructive,

 ;;      interstitial, etc.) and other available information about the condition,

 ;;      as to whether a DLCO test is needed, since it is not useful in all

 ;;      situations. If it may provide useful information about the severity

 ;;      of the condition, it should be requested and reviewed before

 ;;      the examination report is submitted. If the examiner determines that

 ;;      the DLCO test is not needed, a statement as to why not (e.g., there are

 ;;      decreased lung volumes that would not yield valid test results) should be

 ;;      included in the report. Such a statement could avoid a remand from BVA

 ;;      when the test is not done. However in the case of a BVA remand in which

 ;;      the DLCO is requested, the DLCO MUST be done unless there is a medical

 ;;      contraindication.

 ;;

 ;;E. Diagnosis:

 ;;

 ;;      1. In reactivated cases, is this reactivation of the old disease

 ;;         or a separate and distinct new infection?

 ;;

 ;;ADDITIONAL NOTE TO THE EXAMINER:

 ;;

 ;;In all claims, if the disease is inactive and if the inactivity was confirmed

 ;;at a non-VA facility, obtain the name and mailing address of the facility

 ;;from the veteran so that the Regional Office may request the report.

 ;;

 ;;

 ;;Signature:                             Date:

 ;;END

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---DVBCWPM1   3142     printed  Feb 18, 2025@23:20                                                                                                                                                                                                       Page 2

DVBCWPM1  ;ALB/ESW PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 10 Oct 2000

 +1       ;;2.7;AMIE;**34**;Apr 10, 1995

 +2       ;

TXT       ;

 +1       ;;A. Review of Medical Records:

 +2       ;;

 +3       ;;B. Medical History (Subjective Complaints):

 +4       ;;    Comment on:

 +5       ;;

 +6       ;;    1. Activity of pulmonary tuberculosis or other mycobacterial disease. 

 +7       ;;    2. Date of inactivity if it is not active.

 +8       ;;    3. Identity of organism (if possible).

 +9       ;;

 +10      ;;C. Physical examination (Objective Findings):

 +11      ;;    Address each of the following and fully describe current findings:

 +12      ;;

 +13      ;;    1. Extent of structural damage to lungs.

 +14      ;;    2. If patient was hospitalized for 6 months or more, what is the

 +15      ;;       condition at the end of hospitalization?

 +16      ;;    3. If patient was hospitalized for 12 months or more, what is the

 +17      ;;        condition at the end of hospitalization?

 +18      ;;

 +19      ;;D. Diagnostic and Clinical Tests:

 +20      ;;Provide:

 +21      ;;

 +22      ;;1. Pulmonary Function Tests, if indicated. If performed, include the results

 +23      ;;   in the examination report, The FEV-1,FVC, and FEV-1/FVC should be included.

 +24      ;;   Both pre- and post-bronchodilatation pulmonary function test results should

 +25      ;;   be reported. If post-bronchodilatation test is not conducted in a particular

 +26      ;;   case, please provide an explanation of why not. A DLCO may or may not be

 +27      ;;   done routinely as part of pulmonary function testing at a particular

 +28      ;;   facility. If there is a disparity between the results of different tests,

 +29      ;;   please indicate which tests are more likely to accurately reflect

 +30      ;;   the severity of the condition.

 +31      ;;

 +32      ;;      DLCO note: If DLCO was not done as a routine part of pulmonary function

 +33      ;;      testing, the examiner should use his or her judgment, based on

 +34      ;;      the specific condition (.e.g., whether it is obstructive,

 +35      ;;      interstitial, etc.) and other available information about the condition,

 +36      ;;      as to whether a DLCO test is needed, since it is not useful in all

 +37      ;;      situations. If it may provide useful information about the severity

 +38      ;;      of the condition, it should be requested and reviewed before

 +39      ;;      the examination report is submitted. If the examiner determines that

 +40      ;;      the DLCO test is not needed, a statement as to why not (e.g., there are

 +41      ;;      decreased lung volumes that would not yield valid test results) should be

 +42      ;;      included in the report. Such a statement could avoid a remand from BVA

 +43      ;;      when the test is not done. However in the case of a BVA remand in which

 +44      ;;      the DLCO is requested, the DLCO MUST be done unless there is a medical

 +45      ;;      contraindication.

 +46      ;;

 +47      ;;E. Diagnosis:

 +48      ;;

 +49      ;;      1. In reactivated cases, is this reactivation of the old disease

 +50      ;;         or a separate and distinct new infection?

 +51      ;;

 +52      ;;ADDITIONAL NOTE TO THE EXAMINER:

 +53      ;;

 +54      ;;In all claims, if the disease is inactive and if the inactivity was confirmed

 +55      ;;at a non-VA facility, obtain the name and mailing address of the facility

 +56      ;;from the veteran so that the Regional Office may request the report.

 +57      ;;

 +58      ;;

 +59      ;;Signature:                             Date:

 +60      ;;END